Published in Behav Pharmacol on March 01, 1998
Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol (2008) 1.23
Differential behavioral effects of nicotine exposure in adolescent and adult rats. Psychopharmacology (Berl) (2004) 1.13
Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex. Psychopharmacology (Berl) (2006) 1.05
Microdialysis and the neurochemistry of addiction. Pharmacol Biochem Behav (2007) 0.95
Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats. Pharmacol Biochem Behav (2011) 0.87
Previous exposure to nicotine enhances the incentive motivational effects of amphetamine via nicotine-associated contextual stimuli. Neuropsychopharmacology (2012) 0.84
Exposure to nicotine enhances its subsequent self-administration: contribution of nicotine-associated contextual stimuli. Behav Brain Res (2013) 0.78
Differential effects of propranolol on conditioned hyperactivity and locomotor sensitization induced by morphine in rats. Sci Rep (2014) 0.77
Huperzine A inhibits immediate addictive behavior but not behavioral sensitization following repeated morphine administration in rats. Exp Ther Med (2017) 0.75
A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology (1999) 1.42
Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse (1997) 1.39
The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharmacology (Berl) (1995) 1.33
Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport (1996) 1.27
An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend (1998) 1.17
Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization. Synapse (2000) 0.99
Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation. Am J Transplant (2012) 0.96
Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis. Lupus (2012) 0.95
D3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci Biobehav Rev (2001) 0.94
Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritis. Lupus (2011) 0.94
Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients. Am J Transplant (2010) 0.87
Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. J Pharmacol Exp Ther (1999) 0.86
Effects of environmental conditioning on the development of nicotine sensitization: behavioral and neurochemical analysis. Psychopharmacology (Berl) (1996) 0.84
Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians. Clin Exp Immunol (2009) 0.84
Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants. J Pharmacol Exp Ther (1996) 0.81
Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment. Brain Res (1998) 0.81
Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis. Neth J Med (2012) 0.81
The D3 dopamine receptor and substance dependence. J Addict Dis (2001) 0.81
Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil. Lupus (2012) 0.80
Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine. J Pharmacol Exp Ther (1999) 0.80
Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis. Neth J Med (2014) 0.80
Curricular guidelines for residency training in developmental-behavioral pediatrics. J Dev Behav Pediatr (1999) 0.78
Neuropharmacological characterization of local ibogaine effects on dopamine release. J Neural Transm (Vienna) (1996) 0.78
Immunosuppressive therapy in patients with IgA nephropathy. Neth J Med (2015) 0.77
Signal transduction mechanisms and behavioral sensitization to stimulant drugs: an overview of cAMP and PLA2. J Addict Dis (2001) 0.77
Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization. J Pharmacol Exp Ther (1996) 0.77
The polyamine synthesis inhibitor alpha-difluoromethylornithine blocks NMDA-induced neurotoxicity. Eur J Pharmacol (1990) 0.77
Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment. Psychopharmacology (Berl) (1996) 0.76
Kidney transplantation in patients declined by other centres. Neth J Med (2017) 0.75
[Waiting list registration for kidney transplants must improve]. Ned Tijdschr Geneeskd (2017) 0.75
Iterative image restoration. Appl Opt (1975) 0.75